Navigation Links
New Institute for Precision Medicine created at Weill Cornell and NewYork-Presbyterian
Date:1/31/2013

NEW YORK (Jan. 31, 2013) -- Recognizing that medicine is not "one size fits all," Weill Cornell Medical College and NewYork-Presbyterian Hospital have created the pioneering Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center. This new, cutting-edge translational medicine research hub will explore the new frontier of precision medicine, offering optimal targeted, individualized treatment based on each patient's genetic profile. The institute's new genomic research discoveries will help develop novel, personalized medical therapies to be tested in innovative clinical trials, while also building a comprehensive biobank to improve research and patient care.

The Institute for Precision Medicine will be led by Dr. Mark Rubin, a renowned pathologist and prostate cancer expert who uses whole genomic sequencing in his laboratory to investigate DNA mutations that lead to disease, particularly prostate cancer. Dr. Rubin currently serves as vice chair for experimental pathology, director of Translational Research Laboratory Services, the Homer T. Hirst III Professor of Oncology, professor of pathology and laboratory medicine and professor of pathology in urology at Weill Cornell and is a pathologist at NewYork-Presbyterian/Weill Cornell.

Dr. Rubin and his team seek to replace the traditional one-size-fits-all medicine paradigm with one that focuses on targeted, individualized patient care using a patient's own genetic profile and medical history. Physician-scientists at the institute will seek to precisely identify the genetic influencers of a patient's specific illness -- such as cancer, cardiovascular disease, neurodegenerative disease and others -- and use this genetic information to design a more-effective course of treatment that targets those specific contributing factors. Also, genomic analyses of tumor tissue will enable researchers to help patients with advanced disease and no current treatm
'/>"/>

Contact: Lauren Woods
Law2014@med.cornell.edu
646-317-7401
Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. The Montreal Heart Institute designated as a North American Center of Excellence
2. Eric Reiman of Banner Alzheimers Institute awarded Potamkin Prize for Alzheimers research
3. Retina Specialty Institute Gives Patients Something to Look Forward to in Crestview
4. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
5. Institute of Medicine report details for monitoring safety of childhood immunization schedule
6. Cancer Genome Institute at Fox Chase among first to offer clinical blueprint of cancer genes
7. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
8. Patient-Centered Outcomes Research Institute announces 2 awards to Group Health
9. The Spencer Institute Supports New Year’s Resolutions and Long-Term Health with Wellness Coach Certification
10. New Golf Strength and Flexibility Tests from Somax Performance Institute
11. Hangover Research Institute Launched By Hangover Heaven Doctor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 2014 Celebrating its 25th year, ... Americans about the fact that millions of Americans ... and drug addiction and mental health disorders. ... providers, prevention programs and other community groups to ... and neighborhoods. The rallying theme for Substance ...
(Date:8/30/2014)... Saturday 30 August 2014: The first expert consensus ... document compiles current evidence on the diagnosis and ... international experts from three continents. , The "EHRA/HRS/APHRS ... on-line in EP Europace (1). It ... Association (EHRA) of the European Society of Cardiology ...
(Date:8/30/2014)... Saturday 30 August 2014: A new sudden death ... candidates for implantable cardioverter defibrillators (ICDs) in ESC ... Congress by Task Force Chairperson Professor Perry Elliott ... and Management of Hypertrophic Cardiomyopathy" are published today ... (1) and on the ESC Website. Previous ESC ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 The Enchant Him ... this new program actually is a system that promises to ... program was created by Carrie Engel, who actually is a ... that users will get the best advices out there, Carrie ... guru. , This new program is a simple to ...
(Date:8/29/2014)... Berlin, MD (PRWEB) August 30, 2014 ... provided by the Doctors in Delaware at ... variety of free health-related services. In addition to no-cost ... in Maryland offers first aid care at local sports ... and other medical staff provide free disease management ...
Breaking Medicine News(10 mins):Health News:September is National Recovery Month: What the Connecticut Community for Addiction Recovery (CCAR) Wants You to Know 2Health News:September is National Recovery Month: What the Connecticut Community for Addiction Recovery (CCAR) Wants You to Know 3Health News:First expert consensus on ventricular arrhythmias published 2Health News:First expert consensus on ventricular arrhythmias published 3Health News:Sudden death predictor identifies ICD candidates in new ESC Guidelines 2Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3
... Allows Wireless Customers to Contribute $5 to Support,the ... Sept. 2 The Wireless Foundation,and the American ... the U.S. can make a charitable donation to ... Text 2HELP(TM) program. Here,s how it works:,Subscribers of ...
... is,preparing for the upcoming flu season in anticipation ... precautions, robust cleaning,and disinfecting of surface areas and ... are part of the preparations being undertaken at ... for employees,and may extend the shot coverage to ...
... Although what was once,Hurricane Gustav has weakened to a ... stay away from affected areas until authorities,deem it safe ... go home, especially if they think the,danger has passed," ... we ask that people be patient, since conditions are,still ...
... Emergency Procedures Implemented to Make Health Care More Accessible ... for BCBSTX Members Displaced by Hurricane Gustav, DALLAS, Sept. ... Gustav, Blue Cross and Blue Shield of,Texas (BCBSTX) announced several ... gratified that the impact of Hurricane Gustav was less than,originally ...
... may be reluctance to prescribe antidepressants, study suggests , , TUESDAY, ... to be on the rise after a 15-year decline, and ... prescribed antidepressants, a new study suggests. , Researchers thought a ... anomaly. But the new study found the increase in suicides ...
... half of all U.S. adults and nearly two-thirds of obese ... 85, a study based at the University of North Carolina ... a person,s lifetime risk rose as their body mass index ... whose weight was normal at age 18 but were overweight ...
Cached Medicine News:Health News:Wireless Subscribers Can Text 2HELP the American Red Cross 2Health News:Wireless Subscribers Can Text 2HELP the American Red Cross 3Health News:Gilbert Hospital Prepares for Flu Season 2Health News:Red Cross Advises Evacuees to Stay Put Until Conditions Are Safe 2Health News:Blue Cross and Blue Shield of Texas Prepared to Assist Members Affected by Hurricane Gustav 2Health News:Blue Cross and Blue Shield of Texas Prepared to Assist Members Affected by Hurricane Gustav 3Health News:Youth Suicides Continue to Rise in U.S. 2Health News:Youth Suicides Continue to Rise in U.S. 3Health News:Nearly half of US adults will develop painful knee osteoarthritis by age 85: study 2
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will ... the Australian and New Zealand Forensic Science Society,s ... Sciences in Adelaide, Australia . ... concerning the advancements that hyperspectral imaging can bring ... Jeffrey Beckstead , Director of Product Development at ...
(Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... 2011 Nektar Therapeutics (Nasdaq: NKTR ) ... clinical study to evaluate multiple ascending doses of NKTR-181, ... in development as a once- or twice-daily oral tablet ... to address the abuse liability and serious central nervous ...
... 8, 2011 Reportlinker.com announces that a ... its catalogue: Global Intravenous ... http://www.reportlinker.com/p0611078/Global-Intravenous-IV-Solutions-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_E This report analyzes ... in US$ Million. The report provides separate ...
Cached Medicine Technology:Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain 2Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain 3Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain 4Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain 5Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain 6Global Intravenous (IV) Solutions Industry 2Global Intravenous (IV) Solutions Industry 3Global Intravenous (IV) Solutions Industry 4Global Intravenous (IV) Solutions Industry 5Global Intravenous (IV) Solutions Industry 6Global Intravenous (IV) Solutions Industry 7Global Intravenous (IV) Solutions Industry 8
... Operation: , Standby: All toggle switches at off (center ... 50 Hz separated by .75 s; repeats every 10 ... repeat , Tetanus: 50 Hz (50 pulses/s) or ... s); repeat (4 pulses/2 s; repeats every 10 s) ...
... of Operation: , Standby: All toggle switches at ... (1 pulse/s); 10 s (1 pulses/10 s) , ... (100 pulses/s) , Train-Of-Four: Single (4 pulses/2 s); ... , Output Current: Adjustable from 0-70 mA(HI range) ...
... Double Burst : 2 60-ms bursts of 50 Hz ... pulse/s) , Tetanus: 50 Hz (50 pulses/s) or ... pulses/2 s) , Output Current: Adjustable from 0-70 mA ... duration) , Indicators: Battery LED (green) indicates that the ...
... , Standby: A standby switch maintains power to ... 1 s (1 pulse/s) , Tetanus: 100 ... s) , Output Current: Adjustable from 0-70 mA ... (200-us duration) , Indicators: Battery LED (green) indicates ...
Medicine Products: